Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mafalda Ramos, Mark Lamotte, Laetitia Gerlier, Per Svangren, Anna Miquel-Cases & John Haughney. (2019) Cost-effectiveness of physical activity in the management of COPD patients in the UK. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 227-239.
Read now
Read now
Mafalda Ramos, John Haughney, Nathaniel Henry, Leandro Lindner & Mark Lamotte. (2016) Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD. ClinicoEconomics and Outcomes Research 8, pages 445-456.
Read now
Read now
Thomas R. Einarson, Basil G. Bereza, T. Anders Nielsen, Jan Van Laer & Michiel E. H. Hemels. (2016) Systematic review of models used in economic analyses in moderate-to-severe asthma and COPD. Journal of Medical Economics 19:4, pages 319-355.
Read now
Read now
Articles from other publishers (7)
Shuli Qu, Xuedan You, Tianyi Liu, Lijiao Wang, Zheng Yin, Yanjun Liu, Chong Ye, Ting Yang, Mao Huang, Hongchao Li, Liwen Fang & Jinping Zheng. (2021) Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China. npj Primary Care Respiratory Medicine 31:1.
Crossref
Crossref
Ahmed Salem, Heng Zhong, Mafalda Ramos, Mark Lamotte & Hao Hu. (2021) Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China. BMJ Open 11:4, pages e043664.
Crossref
Crossref
Zafar Zafari, Mohsen Sadatsafavi, Wenjia Chen & J. Mark FitzGerald. (2018) The projected economic and health burden of sub-optimal asthma control in Canada. Respiratory Medicine 138, pages 7-12.
Crossref
Crossref
Wouter Poortinga, Sarah E Rodgers, Ronan A Lyons, Pippa Anderson, Chris Tweed, Charlotte Grey, Shiyu Jiang, Rhodri Johnson, Alan Watkins & Thomas G Winfield. (2018) The health impacts of energy performance investments in low-income areas: a mixed-methods approach. Public Health Research 6:5, pages 1-182.
Crossref
Crossref
Zafar Zafari, Stirling Bryan, Don D. Sin, Tania Conte, Rahman Khakban & Mohsen Sadatsafavi. (2017) A Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary Disease. Value in Health 20:1, pages 152-162.
Crossref
Crossref
Simon van der Schans, Lucas M. A. Goossens, Melinde R. S. Boland, Janwillem W. H. Kocks, Maarten J. Postma, Job F. M. van Boven & Maureen P. M. H. Rutten-van Mölken. (2016) Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations. PharmacoEconomics 35:1, pages 43-63.
Crossref
Crossref
MeiLan K Han, Carlos H Martinez, David H Au, Jean Bourbeau, Cynthia M Boyd, Richard Branson, Gerard J Criner, Ravi Kalhan, Thomas J Kallstrom, Angela King, Jerry A Krishnan, Suzanne C Lareau, Todd A Lee, Kathleen Lindell, David M Mannino, Fernando J Martinez, Catherine Meldrum, Valerie G Press, Byron Thomashow, Laura Tycon, Jamie Lamson Sullivan, John Walsh, Kevin C Wilson, Jean Wright, Barbara Yawn, Patrick M Zueger, Surya P Bhatt & Mark T Dransfield. (2016) Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. The Lancet Respiratory Medicine 4:6, pages 473-526.
Crossref
Crossref